Crispr Therapeutics, Vertex get FDA approval for breakthrough gene-editing treatment
December 08, 2023 at 12:03 PM EST
Crispr Therapeutics and Vertex Pharmaceuticals got U.S. regulatory approval for a sickle-cell disease treatment based on the gene-editing technology Crispr.
